Frontlight ResearchEarly access
Trial site
Sanatorio Britanico S.A.
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Phase
- Phase 33 trials
- Status
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Daiichi Sankyo1 trial
- Janssen Research & Development, LLC1 trial
- Pierre Fabre Medicament1 trial
Running trials
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026